Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Registration - 2011 > American Radiolabeled Chemicals, Inc.

Importers Notice of Registration - 2011

[Federal Register Volume 76, Number 116 (Thursday, June 16, 2011)]
[Notices]
[Page 35243]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14974]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 13, 2011, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the following basic classes of controlled substances:

Drug Schedule
Gamma Hydroxybutyric Acid (2010) I
Ibogaine (7260) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Dimethyltryptamine (7435) I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
Dihydromorphine (9145) I
Normorphine (9313) I
Amphetamine (1100) II
Methamphetamine (1105) II
Amobarbital (2125) II
Phencyclidine (7471) II
Phenylacetone (8501) II
Cocaine (9041) II
Codeine (9050) II
Diprenorphine (9058) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Ecgonine (9180) II
Hydrocodone (9193) II
Heroin (9200) II
Meperidine (9230) II
Metazocine (9240) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Oripavine (9330) II
Thebaine (9333) II
Oxymorphone (9652) II
Phenazocine (9715) II
Fentanyl (9801) II

The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 15, 2011.

Dated: June 7, 2011.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2011-14974 Filed 6-15-11; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility